一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Drugs >>article
Drugs

Drugs

IF: 13
Download PDF

Pirfenidone: a review of its use in idiopathic pulmonary fibrosis.

Published:1 February 2015 DOI: 10.1007/s40265-015-0350-9 PMID: 25604027
Esther S Kim, Gillian M Keating

Abstract

Pirfenidone (Esbriet?) is an orally administered, synthetic, pyridone compound that is approved for the treatment of adults with mild to moderate idiopathic pulmonary fibrosis (IPF) in the EU, and for the treatment of IPF in the USA. This article summarizes pharmacological, efficacy and tolerability data relevant to the use of pirfenidone in these indications. In the randomized, double-blind, placebo-controlled, multinational CAPACITY trials in patients with mild to moderate IPF, a significant reduction in the rate of decline in forced vital capacity (FVC) was seen with pirfenidone versus placebo in study 004 but not in study 006. Pirfenidone also reduced the rate of decline in FVC to a significantly greater extent than placebo in the randomized, double-blind, multinational ASCEND trial in this patient population. In addition, pirfenidone showed a significant treatment effect on the 6-min walking test distance and progression-free survival in the ASCEND trial and in a pooled analysis of the CAPACITY trials. Pirfenidone had a manageable tolerability profile in all three studies. Gastrointestinal and skin-related events (e.g. nausea, rash, photosensitivity reaction), which were the most commonly occurring treatment-emergent adverse events, were generally mild to moderate in severity. In addition, a prespecified mortality analysis across all three studies demonstrated a significant reduction in IPF-related and all-cause mortality with pirfenidone. In conclusion, oral pirfenidone is a valuable agent for use in patients with IPF.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Pirfenidone 53179-13-8 C12H11NO 681 suppliers $5.00-$1430.00

Similar articles

IF:13

Fenofibrate: a review of its use in dyslipidaemia.

Drugs Kate McKeage, Gillian M Keating,etc Published: 1 October 2011
IF:4.7

Minoxidil and its use in hair disorders: a review.

Drug Design, Development and Therapy Poonkiat Suchonwanit,?Sasima Thammarucha,etc Published: 9 August 2019
东乡| 新宾| 忻城县| 丹阳市| 永春县| 进贤县| 兰西县| 陇南市| 曲水县| 会同县| 肥西县| 清水县| 鹤山市| 白山市| 马边| 综艺| 响水县| 永泰县| 疏勒县| 蓬莱市| 乡宁县| 渝北区| 江孜县| 逊克县| 慈利县| 山东省| 普洱| 读书| 溧水县| 乐陵市| 黔西县| 资兴市| 泸定县| 水城县| 抚顺市| 杭州市| 乳山市| 旬阳县| 泽州县| 金昌市| 荣成市|